RTW

ODG by MCG to Release Updated Return-to-Work Benchmarks for 2023

Retrieved on: 
Thursday, February 2, 2023

ODG by MCG , an MCG Health company and part of the Hearst Health network, announces the release of updated datasets within the ODG Return-to-Work Guidelines that will support both prospective case management and retrospective benchmarking time away from work.

Key Points: 
  • ODG by MCG , an MCG Health company and part of the Hearst Health network, announces the release of updated datasets within the ODG Return-to-Work Guidelines that will support both prospective case management and retrospective benchmarking time away from work.
  • Updates to duration values for the Australian market are planned for later in 2023.
  • The updated return-to-work benchmarks will be included in both the ODG for Workers’ Compensation and ODG for Disability solutions.
  • Another feature of the ODG solutions, the ODG Risk Assessment Scores, are derivatives of the ODG return-to-work benchmarks and will adjust automatically.

Kerri Rosenthal Names Suzanne Anderson as President

Retrieved on: 
Wednesday, February 8, 2023

WESTPORT, Conn., Feb. 8, 2023 /PRNewswire/ -- Kerri Rosenthal, a luxury lifestyle brand comprised of art, home décor, fashion apparel and accessories all derived from the artist's colorful original art, announces the appointment of Suzanne Anderson as President.

Key Points: 
  • WESTPORT, Conn., Feb. 8, 2023 /PRNewswire/ -- Kerri Rosenthal, a luxury lifestyle brand comprised of art, home décor, fashion apparel and accessories all derived from the artist's colorful original art, announces the appointment of Suzanne Anderson as President.
  • In this role, Anderson will grow the Kerri Rosenthal brand both nationally and internationally through existing and new distribution channels and introduce the vibrant brand to a larger, wider community.
  • "As the Kerri Rosenthal brand continues to grow, we believe that Suzanne will build upon our well-established DNA and prepare us for extensive growth."
  • Additional 2022 collaborations included Kerri Rosenthal x Roller Rabbit; Kerri Rosenthal x Spiritual Gangster; and Kerri Rosenthal x Stripe & Stare.

Orchestra BioMed Debuts as Nasdaq-Traded Company with Lead Programs Targeting Hypertension and Artery Disease and Novel Partnership-Enabled Business Model

Retrieved on: 
Friday, January 27, 2023

NEW HOPE, Pa., Jan. 27, 2023 (GLOBE NEWSWIRE) -- Orchestra BioMed, Inc. (“Orchestra BioMed”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced the closing of its previously announced business combination with Health Sciences Acquisitions Corporation 2 (“HSAC2”) (Nasdaq: HSAQ). Common stock of the combined company (Nasdaq: OBIO or the “Company”), which is called “Orchestra BioMed Holdings, Inc.”, will commence trading on January 27, 2023, on the Nasdaq Global Market under the ticker symbol “OBIO”. Orchestra BioMed’s management team, led by Chairman, Chief Executive Officer and Co-founder David Hochman, will lead the combined company.

Key Points: 
  • Common stock of the combined company (Nasdaq: OBIO or the “Company”), which is called “Orchestra BioMed Holdings, Inc.”, will commence trading on January 27, 2023, on the Nasdaq Global Market under the ticker symbol “OBIO”.
  • Orchestra BioMed’s management team, led by Chairman, Chief Executive Officer and Co-founder David Hochman, will lead the combined company.
  • The business combination, which had previously been approved by Orchestra BioMed stockholders, was approved by HSAC2 shareholders at a special general meeting held on January 24, 2023.
  • Together with proceeds from Orchestra BioMed’s previously completed $110 million Series D financing, total cash following the business combination is expected to provide the Company with a cash runway into 2026.

NUROSENE ANNOUNCES ADVISORY ROLE WITH RARE-X

Retrieved on: 
Wednesday, January 18, 2023

"I am pleased to announce that NetraMark has agreed to an advisory role with RARE-X.

Key Points: 
  • "I am pleased to announce that NetraMark has agreed to an advisory role with RARE-X.
  • As part of the relationship, Dr. Joseph Geraci will join RARE-X's Advisory Board for Xcelerate RARE: An Open Science Data Challenge and RARE-X will provide NetraMark access to their world class rare disease data sets."
  • Core to this advisory role is the RARE-X Open Science Data Challenge which brings together industry leaders, such as the RTW Charitable Foundation, Roche, the Alliance for Artificial Intelligence in Healthcare and includes expert advice from the U.S. Food and Drug Administration, as sited at https://rare-x.org/open-science-data-challenge/ .
  • "We are thrilled that Netramark is partnering with us in this Open Science Data Challenge," said Karmen Trzupek, Senior Director of Scientific Programs for Global Genes.

RARE-X to Launch an Open Science Data Challenge to Address Rare Neurodevelopmental Diseases

Retrieved on: 
Tuesday, January 17, 2023

ALISO VIEJO, Calif., Jan. 17, 2023 /PRNewswire-PRWeb/ -- RARE-X, the Global Genes collaborative platform for rare disease patients to share their data to accelerate the development of diagnoses and treatments, today announced its inaugural Xcelerate RARE: An Open Science Data Challenge to bring together researchers and data scientists to use patient-provided data to address unanswered research questions about rare diseases.

Key Points: 
  • The first Xcelerate RARE challenge will launch in the spring of 2023 and will focus on rare pediatric neurodevelopmental diseases.
  • ALISO VIEJO, Calif., Jan. 17, 2023 /PRNewswire-PRWeb/ -- RARE-X, the Global Genes collaborative platform for rare disease patients to share their data to accelerate the development of diagnoses and treatments, today announced its inaugural Xcelerate RARE: An Open Science Data Challenge to bring together researchers and data scientists to use patient-provided data to address unanswered research questions about rare diseases.
  • "The Open Science Data Challenge is like a long-form hackathon," said Karmen Trzupek, Senior Director of Scientific Programs for Global Genes.
  • Or listen to the RARE-Xtra Podcast on An Open Science Data Challenge to Address Rare Neurodevelopment Diseases.

ReEmployAbility Boosts Its Security Posture with Successful Completion of SOC 2® Type 2 Examination

Retrieved on: 
Monday, December 19, 2022

BRANDON, Fla., Dec. 19, 2022 /PRNewswire-PRWeb/ -- ReEmployAbility, which helps injured or disabled employees get back to meaningful work with nonprofit organizations while they recover, has successfully completed its System and Organizational Controls (SOC) 2® Type 2 examination on controls relevant to Security, Availability, and Confidentiality for Transition2Work services.

Key Points: 
  • ReEmployAbility is committed to data security practices for its clients who rely on them to secure, control, and efficiently manage sensitive personal identifiable information (PII) and program data.
  • "At ReEmployAbility we are passionate about helping people make an impact in their communities," said Abby Torres, ReEmployAbility's IT Director.
  • "Offering reliable and efficient services helps make that possible, and it has made our Transition2Work program the premier choice of return-to-work services.
  • 360 Advanced, Inc., a licensed CPA firm, performed the demanding third-party SOC examination.

Harlem's Fashion Row CEO Partners with Major Retailers to Create Shopping Directory for Black and Latino Designers

Retrieved on: 
Monday, November 21, 2022

NEW YORK, Nov. 21, 2022 /PRNewswire/ -- Brandice Daniel, CEO of Harlem Fashion Row (HFR) and ICON 360, has joined forces with a number of major retailers to create an online shopping directory for Black and Latino designers set to launch on November 21st.

Key Points: 
  • NEW YORK, Nov. 21, 2022 /PRNewswire/ -- Brandice Daniel, CEO of Harlem Fashion Row (HFR) and ICON 360, has joined forces with a number of major retailers to create an online shopping directory for Black and Latino designers set to launch on November 21st.
  • The new online shopping directory, HFR & CO, is a partnership between Harlem's Fashion Row and a group of retailers including Bloomingdales, Shopbob, and Macy's, and others, providing a curated list of emerging brands owned by Black and Latino designers.
  • Instead of scouring the internet or a retailer's website for black designers, HFR & CO allows shoppers to easily find and support these designers through the partnering retailers' websites.
  • Daniel has been championing equity for black designers ever since the inception of Harlem's Fashion Row.

Sag-Aftra Members Against Vax Mandates Speak and Says "End The Mandates Now"

Retrieved on: 
Friday, November 11, 2022

LOS ANGELES, Nov. 11, 2022 /PRNewswire/ -- Sag-Aftra Once Again extended the expiration date of their Return To Work Agreement and Vaccine Mandates. Since its inception, most of the signatory productions are produced under the RTW Agreement, prohibiting work to its own Sag-Aftra members and members of the other entertainment unions who have not taken the covid-19 vaccine injections.

Key Points: 
  • LOS ANGELES, Nov. 11, 2022 /PRNewswire/ -- Sag-Aftra Once Again extended the expiration date of their Return To Work Agreement and Vaccine Mandates.
  • Miami based actor Carlos Guerrero responded to the RTW deadline extension by producing Discriminated Sag-Aftra Members PART 10 "Un-Masking The Mandates" .
  • Among the first to speak out and start this movement are:
    Chuck Slavin , a relentless force leading the exhausting effort behind the movement to end these discriminatory mandates.
  • Slavin is credited with connecting many of the people who are currently in this fight, including Hollywood stars, National and local Sag-Aftra Board Members and other discriminated members.

Allakos Provides Business Update and Reports Third Quarter 2022 Financial Results

Retrieved on: 
Monday, November 7, 2022

SAN CARLOS, Calif., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Allakos Inc. (the Company) (Nasdaq: ALLK), a biotechnology company developing lirentelimab (AK002) and AK006 for the treatment of allergic and inflammatory diseases, today provided a business update and reported financial results for the third quarter ended September 30, 2022.

Key Points: 
  • SAN CARLOS, Calif., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Allakos Inc. (the Company) (Nasdaq: ALLK), a biotechnology company developing lirentelimab (AK002) and AK006 for the treatment of allergic and inflammatory diseases, today provided a business update and reported financial results for the third quarter ended September 30, 2022.
  • Research and development expenses were $18.4 million in the third quarter of 2022 compared to $43.6 million in the third quarter of 2021.
  • General and administrative expenses were $13.0 million in the third quarter of 2022 compared to $19.1 million in the third quarter of 2021.
  • These documents contain and identify important factors that could cause the actual results for Allakos to differ materially from those contained in Allakos forward-looking statements.

'The Sandlot' Actor, Patrick Renna, Launches HAMBINO ATHLETICS: Nostalgic, Baseball-Inspired Family Clothing Brand + Charitable Foundation

Retrieved on: 
Thursday, November 3, 2022

To build the brand, Renna tapped longtime friend and fashion industry veteran Jessie Willner , founder of Los Angeles-based brand, The Mighty Company .

Key Points: 
  • To build the brand, Renna tapped longtime friend and fashion industry veteran Jessie Willner , founder of Los Angeles-based brand, The Mighty Company .
  • With experience building a brand both visually and organizationally, Willner oversees the production and creative direction of HAMBINO.
  • At its core, HAMBINO is a family brand and the product line reflects that.
  • The Hambino Foundation provides support to young athletes and youth organizations in underserved communities throughout the United States.